LFST vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, PRVA, CON, and TDOC
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs.
Guardant Health (NASDAQ:GH) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, community ranking, media sentiment and profitability.
Guardant Health has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.
In the previous week, Guardant Health had 12 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Guardant Health and 1 mentions for LifeStance Health Group. Guardant Health's average media sentiment score of 0.54 beat LifeStance Health Group's score of -0.50 indicating that Guardant Health is being referred to more favorably in the media.
Guardant Health received 276 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 70.52% of users gave Guardant Health an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote.
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 5.5% of Guardant Health shares are held by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
LifeStance Health Group has a net margin of -7.90% compared to Guardant Health's net margin of -74.02%. LifeStance Health Group's return on equity of -6.66% beat Guardant Health's return on equity.
Guardant Health presently has a consensus target price of $43.24, indicating a potential downside of 2.70%. LifeStance Health Group has a consensus target price of $8.70, indicating a potential upside of 12.62%. Given LifeStance Health Group's higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than Guardant Health.
LifeStance Health Group has higher revenue and earnings than Guardant Health. LifeStance Health Group is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.
Summary
Guardant Health beats LifeStance Health Group on 10 of the 18 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 2/21/2025 by MarketBeat.com Staff
